Pharmaceutical Network November 24th. People insiders learned，"Administrative Measures for Chinese Medicine Formula Granules" is soliciting opinions，The text will soon be announced。In the future, the regulatory authorities will let go of the production pilot of the formula particles，Chinese medicine manufacturers are approved by the provincial food and drug supervision and management department of the local area，Add Chinese medicine formula granules to the production scope of the "Drug Production License" of the enterprise，You can follow the requirements of the "Implementation Rules for the Management Implementation of Chinese Medicine Formula Granules"，It can be produced after submitting the filing information of traditional Chinese medicine formula particles to the provincial food and drug supervision and management department where the local food and drug supervision and management department is located。

 

 

Pilot restrictions are expected to let go

 

 

Chinese medicine formula particles are also called & ldquo; Single -flavored Chinese medicine concentrated particles & rdquo;、& ldquo; Chinese medicine new type of granules & rdquo; et al.，It is a raw material based on the Chinese medicine tablets that meet the standards of the processing.，Extraction of modern crafts、Concentration、Dry、Pure traditional Chinese medicine product series made of granules。It can ensure all the features of the original Chinese medicine tablets，At the same time, no need to fry，can be taken directly，It is easy to carry and save，Easy to modulate and suitable for industrial production。

 

 

The above person said，Stake Sports BettingThe My stake betting appbiggest highlight of the lecture on this comments，As the regulatory department will let go of the pilot limit of the formula particles。July 2001，The State Drug Administration issued the "Interim Provisions on the Management of Chinese Medicine Formula Granules"，Clearly incorporate Chinese medicine formula particles into the category of Chinese medicine drinking tablets。Due to the incomplete production process、Enterprise quality standards are inconsistent、Clinical research still has problems such as limitations，Always，State Drug Administration's qualifications of pilot manufacturers are strictly controlled，Only approved 6 companies pilot production，To formulate a unified industry standard。These 6 Chinese medicine companies are China Resources Three Nine、Tianjiang Pharmaceutical、Beijing Kangrentang Pharmaceutical, a subsidiary of Hongri Yao Industry、Peili (Nanning) Pharmaceutical、Sichuan New Green Pharmaceutical and Guangdong Pharmaceutical Pharmaceutical。

 

 

After letting go of production restrictions，Chinese medicine manufacturers are approved by the provincial food and drug supervision and management department where the company is located，Add Chinese medicine formula granules to the production scope of the "Drug Production License" of the enterprise，Then you can follow the requirements of the "Implementation Rules for the Management Implementation of Chinese Medicine Formula Granules"，It can be produced after submitting the filing information of traditional Chinese medicine formula particles to the provincial food and drug supervision and management department where the local food and drug supervision and management department is located。

 

 

Introduction to industry insiders，The record conditions include the scope of the production of granular agents，Have Chinese medicine drinking tablets、Extract、Concentration、Dry、granulation and other complete production capacity，meets GMP requirements; quality regulators，Pharmaceutical testing at the same time，and promise to bear risk liability。

 

 

After implementing the management of the filing system，Regulatory authorities will review through the source of medicinal materials、Flying Inspection and Blacklist System of Food and Drug Administration、The provincial bureau is not less than twice a year of daily inspections、Strictly investigate and prescriptions and other means to implement rigorous management of the industry。

 

 

Visty market space

 

 

According to the estimation of industry insiders，The market size of Chinese medicine particles in 2013 is about 5 billion yuan，The compound growth rate of the past 5 years is 40%-50%。Make an estimate，By 2016, the annual sales of traditional Chinese medicine formula granules will reach 10 billion yuan。

 

 

Japan、Korea、Taiwan and other places in China stake betting appbegan My stake betting appto develop granules in the 1970s，and win the international market with Chinese medicine formula granules。my country has gone through more than 20 years of independent research and development，In 2001, the China Drug Administration officially named Chinese medicine formula granules，To 2010，Production specifications of more than 600 flavors of traditional Chinese medicine formula particles。

 

With the advancement of the reform of public hospitals，County -level hospitals have completely canceled the drug bonus。Increased income pressure in the hospital，and the formula particles are executed according to Chinese medicine drinks，Still executing 25%bonus。Industry insiders think，This will accelerate the enthusiasm of the hospital's use of Chinese medicine formula particles，Chinese medicine formula particles in the next 3 years will still maintain a growth rate of about 30%，By 2016, the overall market size is expected to exceed 10 billion yuan，will increase to 20 billion yuan from 2018。

 

 

Previous，​​In addition to some hospitals in some areas，Traditional Chinese Medicine Formula Granules belong to the category of self -funded，But with the use of traditional Chinese medicine formula particles, more and more，The call to the medical insurance is getting higher and higher。

 

 

August 24，Chinese medicine formula particles are included in the scope of the basic medical insurance payment scope of Zhejiang Province for pilot soliciting opinions; Shaanxi Province restricts drug retail enterprises' operating sales rights for traditional Chinese medicine formula particles。

 

 

Display of Opinions，Zhejiang Province intends to include the scope of medical insurance reimbursement for the recipe particles of traditional Chinese medicine after September 1 this year，But Chinese medicine formula particles are included in the basic medical insurance pilot scope limited to provincial level three or above Chinese medicine hospitals，Payment varieties、Use management and price devices shall be implemented in accordance with the relevant management regulations of traditional Chinese medicine tablets。BOC Securities Medical Researcher Wang Jun believes，This pilot is a milestone incident for the sales promotion of traditional Chinese medicine formulas。& ldquo; Current，Only a few cities such as Qingdao and Hangzhou have incorporated Chinese medicine formulas into the scope of local medical insurance。In some areas，Chinese medicine formula particles are only part of the Chinese medicine drinking tablets and are included in local medical insurance，For example, stake online sports bettingsome My stake betting apphigh -end hospitals in Beijing。Zhejiang is the first Chinese medicine formula particles as independent medicines，instead of a part of other related products to be included in the province of local medical insurance。Patients taking this type of drug daily expenses are not cheap，Chronic diseases require 50-60 yuan，Cough requires 10-15 yuan。Zhejiang's pilot will create more sales and promotion opportunities for traditional Chinese medicine formula particles。& rdquo;

 

 

Pharmaceutical companies are scrambling to lay out

 

 

According to industry insiders，The international standards of the traditional Chinese medicine formula particles industry have passed the discussion of the World Chinese Medicine Federation，Domestic standards are also in the formulation process，The industry's expectations for recent release of production qualifications are more strong。

 

 

& ldquo; The proportion of traditional Chinese medicine formula particles in the Chinese medicine market in my country is less than 2%，There is a huge room for improvement。In addition，The technical threshold of the Chinese medicine formula granules is not high，and the average gross profit margin is as high as 70%，Broad market prospects，Other companies are definitely unwilling to let go。& rdquo; Shi Lichen, head of Beijing Dingchen Medical Management Consultation Center, said。

 

 

Fo Che Pharmaceutical announced in June this year，Transferred to the Chinese Medicine Formula Millet Secret Technology of the Lanzhou Chemical Institute。From the perspective of Southwest Securities Analyst Zhu Guoguang，This is the layout of Buddhist Pharmaceutical to seize the market opportunity。At present, the traditional Chinese medicine formula particles in the Northwest are still blank，The market development is relatively weak，​​Buddha Pharmaceutical is expected to take the lead in capturing the Northwest Market with geographical advantages，Then radiate the whole country。

 

 

In addition，Kangmei Pharmaceutical、Essence Pharmaceutical and other listed pharmaceutical companies are also actively deploying。Kangmei Pharmaceuticals in the reserved area of ​​the second phase of the Chinese medicine drinking tablet，Expansion of the production of Chinese medicine formula particles production automation and online quality monitoring technology transformation project。According to company executives，The company was preparing this technology a few years ago，It is ready at present; Essence Pharmaceuticals means，Its subsidiary subsidiary Essence Pharmaceutical Bozhou Kangpu Co., Ltd. stake betting apphas stake betting appthe production workshop of traditional Chinese medicine drinks，After the policy is open，The factory will gradually enter the production of Chinese medicine formula particles in the future。It is understood，Xiangxue Pharmaceutical also has the idea of ​​exterior expansion in this field。